VeraLight gets approval for diabetes testing device in Canada

04/26/2011 | American City Business Journals

Health Canada has given VeraLight the go-ahead to commercialize Scout, a less-invasive device that uses light to quickly detect pre-diabetes or type 2 diabetes. The company is awaiting marketing approval in the European Union and hopes to secure about $15 million to seek FDA approval for the device.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC